Company: PTPI
Filing Date: 2025-02-19
Form Type: 424B4
Source: 0001410578-25-000164
Chunk: 3

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-02-19
Form: 424B4
Chunk 3
---
 any of the securities we are offering and Dawson James is not required to arrange the purchase or sale of any specific number of securities or dollar amount. We have agreed to pay to Dawson James the placement agent fees set forth in the table below. We will bear all costs associated with the offering. See “Plan of Distribution” on page 73 of this prospectus for more information regarding these arrangements. The public offering price per Unit was determined between us, Dawson James and the investors in this offering at the time of pricing. There is no established public trading market for each of the Series Warrants or the Pre-Funded Warrants, and we do not expect a market to develop. In addition, we do not intend to apply for the listing of either of the Series Warrants or the Pre-Funded Warrants on any national securities exchange. Without an active trading market, the liquidity of the Series Warrants and the Pre-Funded Warrants will be limited. We will have one closing for all the securities purchased in this offering. The public offering price per Unit will be fixed for the duration of this offering.

|                                     |   | Per                       
 Share of Common Stock and 
 Series Warrants           |        |   | Per Pre-Funded  
 Warrant and     
 Series Warrants |        |   | Total |           |   |
|:------------------------------------|:--|:--------------------------|-------:|:--|:----------------|-------:|:--|:------|----------:|:--|
| Public offering price               | ​ | $                         |   0.24 | ​ | $               | 0.2399 | ​ | $     | 9,597,395 | ​ |
| Placement Agent fees(1)             | ​ | $                         | 0.0192 | ​ | $               | 0.0192 | ​ | $     |   768,000 | ​ |
| Proceeds, before expenses, to us(2) | ​ | $                         | 0.2208 | ​ | $               | 0.2207 | ​ | $     | 8,829,395 | ​ |

(1)We have agreed to pay Dawson James a total cash fee equal to 8% of the aggregate gross proceeds raised in this offering and to reimburse Dawson James for its legal fees and expenses and other out-of-pocket expenses in an amount up to $125,000. See “ Plan of Distribution” for a description of the compensation to be received by Dawson James.